Physician profile
Paul E Buckthal
NPI 1609840271
$821.01
in general payments reported to CMS, 2019-2025
9 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.83 · 2020: $110 · 2021: $75.57 · 2022: $20.97 · 2023: $216 · 2024: $165 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $563.29 | 2021-2025 | |
| Lilly USA, LLC | $71.67 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $56.33 | 2019-2020 | |
| Argenx US, INC. | $29.41 | 2025 | Vyvgart Hytrulo |
| Acadia Pharmaceuticals INC | $27.95 | 2019 | |
| Supernus Pharmaceuticals, INC. | $25.04 | 2019-2020 | |
| Celgene Corporation | $17.68 | 2023 | Zeposia |
| Biogen, INC. | $14.91 | 2020 | |
| Abbvie INC. | $14.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Buckthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.